Get the Stockscreener App
147.60
1.13%
1.65
After Hours:
147.60
Overview
News
Price History
Option Chain
Financials
Why CLX Down?
Discussions
Forecast
Stock Split
Dividend History
Clorox Co stock is traded at $147.60, with a volume of 1.56M.
It is up +1.13% in the last 24 hours and down -6.34% over the past month.
Since its inception more than 100 years ago, Clorox has grown to play in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just less than 85% of Clorox's sales stem from its home turf.
See More
Previous Close:
$145.95
Open:
$146.96
24h Volume:
1.56M
Relative Volume:
1.33
Market Cap:
$18.18B
Revenue:
$7.47B
Net Income/Loss:
$357.00M
P/E Ratio:
51.43
EPS:
2.87
Net Cash Flow:
$669.00M
1W Performance:
-8.01%
1M Performance:
-6.34%
6M Performance:
+3.05%
1Y Performance:
-4.63%
1-Day Range:
$145.66
$148.67
1-Week Range:
$145.19
$161.45
52-Week Range:
$127.60
$171.37
Clorox Co Stock (CLX) Company Profile
Name
Clorox Co
Sector
Industry
Phone
(510) 271-7000
Address
THE CLOROX COMPANY, OAKLAND, CA
Compare CLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLX
Clorox Co
|
147.60 | 18.18B | 7.47B | 357.00M | 669.00M | 2.87 |
|
PG
Procter Gamble Co
|
168.88 | 396.00B | 84.35B | 15.48B | 15.47B | 6.28 |
|
UL
Unilever Plc Adr
|
58.07 | 144.70B | 64.93B | 7.15B | 0 | 2.832 |
|
CL
Colgate Palmolive Co
|
85.68 | 70.00B | 20.10B | 2.89B | 3.55B | 3.52 |
|
KMB
Kimberly Clark Corp
|
128.69 | 42.70B | 20.06B | 2.55B | 2.51B | 7.55 |
|
KVUE
Kenvue Inc
|
19.80 | 37.96B | 15.46B | 1.06B | 1.40B | 0.55 |
Clorox Co Stock (CLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Nov-06-24 | Upgrade | TD Cowen | Sell → Hold |
| Oct-01-24 | Upgrade | Jefferies | Hold → Buy |
| Jul-23-24 | Initiated | TD Cowen | Sell |
| Jun-24-24 | Initiated | Exane BNP Paribas | Underperform |
| Apr-02-24 | Downgrade | Citigroup | Buy → Neutral |
| Mar-26-24 | Upgrade | Jefferies | Underperform → Hold |
| Mar-01-24 | Resumed | Goldman | Sell |
| Feb-05-24 | Downgrade | DA Davidson | Buy → Neutral |
| Dec-15-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Nov-22-23 | Upgrade | JP Morgan | Underweight → Neutral |
| Nov-13-23 | Initiated | Jefferies | Underperform |
| Nov-06-23 | Upgrade | UBS | Sell → Neutral |
| Nov-02-23 | Upgrade | Citigroup | Neutral → Buy |
| Oct-12-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Oct-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-02-23 | Upgrade | DA Davidson | Neutral → Buy |
| Sep-22-23 | Initiated | HSBC Securities | Hold |
| Aug-03-23 | Upgrade | Atlantic Equities | Underweight → Neutral |
| Feb-17-23 | Initiated | Citigroup | Neutral |
| Oct-18-22 | Initiated | Evercore ISI | Underperform |
| Oct-17-22 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Sep-14-22 | Resumed | BofA Securities | Underperform |
| Jul-13-22 | Initiated | Raymond James | Outperform |
| Feb-04-22 | Downgrade | Atlantic Equities | Neutral → Underweight |
| Feb-04-22 | Reiterated | Deutsche Bank | Hold |
| Feb-04-22 | Reiterated | JP Morgan | Underweight |
| Feb-04-22 | Reiterated | Morgan Stanley | Underweight |
| Feb-04-22 | Reiterated | UBS | Sell |
| Feb-04-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | Bernstein | Mkt Perform → Underperform |
| Jan-26-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-02-21 | Reiterated | DA Davidson | Neutral |
| Nov-02-21 | Reiterated | Deutsche Bank | Hold |
| Nov-02-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-02-21 | Reiterated | Wells Fargo | Underweight |
| Sep-03-21 | Downgrade | Argus | Buy → Hold |
| Aug-04-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Aug-04-21 | Reiterated | Citigroup | Buy |
| Aug-04-21 | Reiterated | Credit Suisse | Neutral |
| Aug-04-21 | Reiterated | Deutsche Bank | Hold |
| Aug-04-21 | Reiterated | Morgan Stanley | Underweight |
| Aug-04-21 | Reiterated | RBC Capital Mkts | Sector Perform |
| Aug-04-21 | Reiterated | UBS | Sell |
| Aug-04-21 | Reiterated | Wells Fargo | Underweight |
| Jun-24-21 | Initiated | UBS | Sell |
| May-03-21 | Downgrade | Wells Fargo | Overweight → Underweight |
| Mar-18-21 | Downgrade | DA Davidson | Buy → Neutral |
| Feb-19-21 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jan-20-21 | Initiated | Bernstein | Mkt Perform |
| Dec-14-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-08-20 | Initiated | Wells Fargo | Overweight |
| Oct-16-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-20 | Initiated | DA Davidson | Buy |
| Mar-19-20 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-16-20 | Upgrade | JP Morgan | Underweight → Overweight |
| Mar-09-20 | Upgrade | Argus | Hold → Buy |
| Oct-03-19 | Reiterated | BofA/Merrill | Neutral |
| Sep-23-19 | Downgrade | Barclays | Equal Weight → Underweight |
| May-20-19 | Downgrade | Argus | Buy → Hold |
| May-02-19 | Reiterated | BofA/Merrill | Neutral |
| May-02-19 | Upgrade | Deutsche Bank | Sell → Hold |
| Apr-08-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-07-19 | Initiated | Credit Suisse | Outperform |
| Dec-06-18 | Reiterated | BofA/Merrill | Neutral |
| Sep-25-18 | Upgrade | Argus | Hold → Buy |
| Jul-18-18 | Downgrade | Goldman | Neutral → Sell |
| Apr-19-18 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-08-18 | Downgrade | Argus | Buy → Hold |
| Jan-04-18 | Upgrade | BofA/Merrill | Underperform → Neutral |
View All
Clorox Co Stock (CLX) Latest News
Clorox Co. stock outperforms competitors on strong trading day - MarketWatch
Decoding Clorox Co (CLX): A Strategic SWOT Insight - GuruFocus.com
BlackRock, Inc.'s Strategic Acquisition of Clorox Co. Shares - GuruFocus.com
Clorox Raises Guidance After Quarterly Sales Top Estimates - MSN
The Clorox Company (NYSE:CLX) Q2 2025 Earnings Call Transcript - Insider Monkey
2 High-Yield Consumer Staples Stocks Ready to Deliver Big Returns - Investing.com
2 High-Yield Consumer Staples Stocks Ready to Deliver Big Returns - Benzinga
Clorox Stock In Focus After Q2 Earnings Beat, Raised EPS Outlook: Retail Stays Bullish - MSN
Clorox Co. stock underperforms Tuesday when compared to competitors - MSN
Clorox defends $580M digital transformation efforts - CIO Dive
Clorox to Present at 2025 CAGNY Conference – Company Announcement - Financial Times
Why Clorox (CLX) Shares Are Getting Obliterated Today - Barchart
Why Clorox (CLX) Shares Are Getting Obliterated Today By Stock Story - Investing.com Canada
Clorox shares under pressure as cautious outlook overshadows FQ2 beat (CLX:NYSE) - Seeking Alpha
Clorox Analysts Boost Their Forecasts Following Upbeat Earnings - Benzinga
Clorox (NYSE:CLX) Shares Gap DownHere's Why - MarketBeat
Clorox (NYSE:CLX) Price Target Raised to $155.00 at Evercore ISI - MarketBeat
Clorox Beats Q2 Earnings & Sales Estimates, Updates FY25 Outlook - Yahoo Canada Finance
Clorox's SWOT analysis: stock faces challenges amid market share gains - Investing.com
Clorox's SWOT analysis: stock faces challenges amid market share gains By Investing.com - Investing.com UK
Clorox Beats Expectations Despite 15% Sales Drop, CEO Stays Confident In Q4 Growth - Benzinga
Clorox (CLX) PT Raised to $189 at Jefferies - StreetInsider.com
CLX Earnings: Clorox Raises Guidance after Surpassing Quarterly Expectations - Markets Insider
Clorox Co (CLX) Q2 2025 Earnings Call Highlights: Strategic Moves and Challenges Ahead - Yahoo Finance
Clorox Earnings: Even Amid the Racket From Its 2023 Cyberattack, Brand Strength Proves Unwavering - Morningstar
Barclays maintains Clorox stock Underweight with $130 target By Investing.com - Investing.com Australia
Clorox Reports Q2 2025 Results and Strategic Updates - TipRanks
Clorox: Fiscal Q2 Earnings Snapshot - Barchart
Barclays maintains Clorox stock Underweight with $130 target - Investing.com India
Earnings call transcript: Clorox beats Q2 2024 forecasts, stock dips By Investing.com - Investing.com Canada
Clorox Q2 earnings top estimates, raises full-year outlook - MSN
Earnings call transcript: Clorox beats Q2 2024 forecasts, stock dips - Investing.com
Clorox Co (CLX) Q2 Earnings: EPS Surges to $1.54, Revenue Hits $1.69 Billion, Exceeding Estimates - GuruFocus.com
Clorox earnings beat by $0.16, revenue topped estimates - Investing.com
Clorox: Fiscal Q2 Earnings Snapshot -February 03, 2025 at 05:29 pm EST - Marketscreener.com
Forsta AP Fonden Trims Stock Holdings in The Clorox Company (NYSE:CLX) - MarketBeat
Clorox Stock Slides On Q2 EarningsClorox (NYSE:CLX) - Benzinga
Q2 2025 Clorox Co Earnings Call Transcript - GuruFocus.com
Clorox’s (NYSE:CLX) Q4: Beats On Revenue - Yahoo Finance
Clorox (CLX) Raises Guidance After Quarterly Sales Top Estimates - Bloomberg
Clorox Reports Q2 Fiscal Year 2025 Results, Updates Outlook - Yahoo Finance
Clorox Q2 25 Earnings Conference Call At 5:00 PM ET - Nasdaq
Clorox Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
CENTRAL TRUST Co Sells 1,803 Shares of The Clorox Company (NYSE:CLX) - MarketBeat
Tyson Foods, Clorox And 3 Stocks To Watch Heading Into Monday - Benzinga
The Clorox Company (NYSE:CLX) Shares Acquired by Robeco Institutional Asset Management B.V. - MarketBeat
Clorox (CLX) Q4 Earnings: What To Expect - The Globe and Mail
Clorox (CLX) Q4 Earnings: What To Expect By Stock Story - Investing.com Canada
Swedbank AB Acquires 7,068 Shares of The Clorox Company (NYSE:CLX) - MarketBeat
The Clorox Company (NYSE:CLX) Shares Sold by Pacer Advisors Inc. - MarketBeat
TCI Wealth Advisors Inc. Decreases Position in The Clorox Company (NYSE:CLX) - MarketBeat
Clorox Co Stock (CLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.55%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):